3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
26
Pain, Postoperative
17
Neoplasms
13
Lung Neoplasms
12
Brain Neoplasms
12
Depression
7
Carcinoma, Hepatocellular
7
Pain
6
Colonic Neoplasms
6
Thyroid Neoplasms
5
Stomach Neoplasms
5
Prostatic Neoplasms
5
Leiomyoma
5
Head and Neck Neoplasms
5
Agnosia
5
Ovarian Neoplasms
4
Multiple Myeloma
4
Delirium
4
Colorectal Neoplasms
4
Anxiety Disorders
4
Supratentorial Neoplasms
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Myofibroma
3
Lymphoma
3
Hemorrhage
3
Fatigue
3
Emergence Delirium
3
Chronic Pain
3
Carcinoma, Non-Small-Cell Lung
3
Interventions
Carboplatin
75
Paclitaxel
68
Bevacizumab
44
Taxes
22
Cyclophosphamide
21
pembrolizumab
19
Gemcitabine
19
Cisplatin
18
Topotecan
17
Hyperthermic Intraperitoneal Chemotherapy
14
olaparib
13
liposomal doxorubicin
13
Immunoglobulin G
13
Disulfides
13
Specimen Handling
11
Drug Therapy
11
niraparib
10
Cytoreduction Surgical Procedures
10
Magnetic Resonance Spectroscopy
9
sargramostim
7
Surveys and Questionnaires
7
Doxorubicin
7
Docetaxel
7
durvalumab
6
Platinum
6
Nivolumab
6
Letrozole
6
Granulocyte-Macrophage Colony-Stimulating Factor
6
Biopsy
6
Albumin-Bound Paclitaxel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Fallopian Tube Neoplasms
×
Saline Solution
×
Clear all
NCT04201561
2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3
Unknown
68 enrolled